Peri- and Post-procedural Anticoagulation with Left Atrial Appendage Occlusion Devices

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Device Technology

Background:

• Atrial fibrillation increases stroke risk due to left atrial appendage thrombus formation.
• Anticoagulation is standard for stroke prevention but carries bleeding risks.
• Percutaneous left atrial appendage occlusion (LAAO) offers an alternative for high-risk patients.

Purpose of the Study:

• To review peri- and post-procedural anticoagulation/antithrombotic therapy after LAAO.
• To discuss complications, device-related thrombosis, and incomplete occlusion risks.
• To identify literature limitations and gaps in LAAO management.

Main Methods:

• Literature review of current studies on LAAO.
• Analysis of anticoagulation protocols and outcomes.
• Examination of procedural complication rates and thrombosis risks.

Main Results:

• Standardized peri- and post-procedural antithrombotic strategies are crucial for LAAO success.
• Device-related thrombosis and incomplete occlusion are significant risks requiring monitoring.
• Optimal antithrombotic regimens post-LAAO are still under investigation.

Conclusions:

• LAAO is a viable stroke prevention option for select atrial fibrillation patients.
• Careful management of antithrombotic therapy and monitoring for complications are essential.
• Further research is needed to optimize LAAO protocols and long-term outcomes.